INFUSE BONE GRAFT LARGE KIT 7510600

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,03,05 report with the FDA on 2010-10-29 for INFUSE BONE GRAFT LARGE KIT 7510600 manufactured by Medtronic Sofamor Danek Usa, Inc.

Event Text Entries

[1756201] It is reported that rhbmp-2 was used in mandibular reconstruction in this (b)(6) female following resection for ameloblastoma. The patient presented with an edentulous, residual segmental defect spanning right mandibular body to left mandibular angle and measuring 80. 7 mm. The defect was reconstructed with a 2. 4 mm reconstruction plate. A trans-cervical approach was used to create a pocket of tissue surrounding the plate wherein a cadaveric rib, previously soaked in saline, was adapted superior to the plate and secured with 12 mm bone screws on either side of the defect. A total of 24 mg rhbmp-2 /acs was placed passively into the pocket, followed by a standard layered closure. There were no surgical complications. At three months, radiographic exam revealed some calcified areas in the anterior and postero-superior aspect of the defect. Six and eight-month radiographs revealed minimal final bone formation in the segmental defect. Conventional mandibular reconstruction via iliac crest graft was successfully performed 12 months following the initial reconstruction attempt with rhbmp-2. The patient has now been fully rehabilitated with an implant-supported fixed prosthesis in the area of her segmental defect. Among the possible factors that may have lead to insufficient bone formation, the authors suggest: the absorbable collagen sponge (asc) was placed in a periosteal pocket and "tented" with cadaveric rib - since the acs lacks any structural stability, it may have collapsed around the rib, or the cadaveric rib may have provided an insufficient framework necessary for adequate bone formation.
Patient Sequence No: 1, Text Type: D, B5


[8892066] (b)(4) - pseudarthrosis. Literature citation: glied, et al). Off-label use of rhbmp-2 for reconstruction of critical-sized mandibular defects. Three case reports. Nysdj 2010 june/july. A review of the certificates of analysis and packing list for the infuse bone graft was not possible without additional device info. Without return of the device or associated records, it is not possible to ascertain a cause for the reported event.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1030489-2010-01397
MDR Report Key1893069
Report Source01,03,05
Date Received2010-10-29
Date of Report2010-10-14
Date of Event2010-06-01
Date Mfgr Received2010-10-14
Date Added to Maude2010-11-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactCHAD ASHTON
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal38132
Manufacturer Phone9013963133
Manufacturer G1MEDTRONIC SOFAMOR DANEK USA, INC.
Manufacturer Street4340 SWINNEA RD.
Manufacturer CityMEMPHIS TN 38118
Manufacturer CountryUS
Manufacturer Postal Code38118
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINFUSE BONE GRAFT LARGE KIT
Generic NameINFUSE BONE GRAFT
Product CodeNPZ
Date Received2010-10-29
Model NumberNA
Catalog Number7510600
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC SOFAMOR DANEK USA, INC
Manufacturer Address4340 SWINNEA RD. MEMPHIS TN 38118 US 38118


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2010-10-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.